Will get back to you on the success of Ivermectin and its success in early treatment.
If it wasn't so successful, my own doctor would not be prescribing hydroxy and ivermectin. She's has a 99% success rate with only 1 hospitalization. Her patients include various ages, including v. old age. She also has clients in multiple nursing homes that have rec'd the treatment.
First hand knowledge is nice. I accept it whether or not you do or don't.
Again, I will get back to you with some succesful studies on ivermectin.
As Dr. Pierre Kory, Lung Specialist and Associate Professor of Medicine at St. Luke’s Aurora Medical Center, has attested to, profound anti-viral and anti-inflammatory properties of Ivermectin have been identified.
In COVID-19 specifically, studies show that one of its several anti-viral properties is that it strongly binds to the spike protein, keeping the virus from entering the cell.
These effects, along with its multiple abilities to control inflammation, both explain the markedly positive trial results already reported.
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 “Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.”
News 
Market Data 
Discover 
